http://orcid.org/0000-0001-8209-8248
References
- Obstetricians ACo, Gynecologists. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122.
- Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstetrics Gynecol Reprod Biol. 2013;170(1):1–7.
- Van Lerberghe W. The world health report 2005: make every mother and child count. Geneva, Switzerland: World Health Organization; 2005.
- Gilbert JS, Ryan MJ, LaMarca BB, et al. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294(2):H541–H550.
- Leijnse JE, de Heus R, de Jager W, et al. First trimester placental vascularization and angiogenetic factors are associated with adverse pregnancy outcome. Pregnancy Hypertens. 2018;13:87–94.
- Silva D, Marreiro D, Moita Neto JM, et al. Oxidative stress and immunological alteration in women with preeclampsia. Hypertens Pregnancy. 2013;32(3):304–311.
- Guida JP, Parpinelli MA, Surita FG, Costa ML. The impact of proteinuria on maternal and perinatal outcomes among women with pre‐eclampsia. Int J Gynecol Obstet. 2018;143(1):101–107.
- Newman MG, Robichaux AG, Stedman CM, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol. 2003;188(1):264–268.
- Tranquilli A, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97.
- Mateus J, Newman R, Sibai BM, et al. Massive urinary protein excretion associated with greater neonatal risk in preeclampsia. AJP Rep. 2017;7(1):e49.
- Parlakgümüş HA, Şimşek E, Çok T, et al. The relationship between proteinuria in severe preeclampsia and maternal and fetal outcomes. Gynecology Obstet Reprod Med. 2012;18:1.
- Bouzari Z, Javadiankutenai M, Darzi A, et al. Does proteinura in preeclampsia have enough value to predict pregnancy outcome. Clin Exp Obstet Gynecol. 2014;41(2):163–168.
- Fluss R, Faraggi D, Reiser B. Estimation of the youden index and its associated cutoff point. Biomet J J Math Methods Biosci. 2005;47(4):458–472.
- Dekker GA. Management of preeclampsia. Pregnancy Hypertens. 2014;4(3):246–247.
- English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015;8:7.
- Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecology Canada. 2014;36(5):416–438.
- Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol. 2007;18(8):2281–2284.
- Lindheimer MD, Kanter D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstetrics Gynecol. 2010;115(2):365–375.
- von Dadelszen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377(9761):219–227.
- Payne B, Magee LA, Côté A-M, et al. PIERS proteinuria: relationship with adverse maternal and perinatal outcome. J Obstet Gynaecology Canada. 2011;33(6):588–597.
- van der Tuuk K, Holswilder-Olde Scholtenhuis M, Koopmans C, et al. Prediction of neonatal outcome in women with gestational hypertension or mild preeclampsia after 36 weeks of gestation. J Matern Fetal Neonatal Med. 2015;28(7):783–789.
- Dong X, Gou W, Li C, et al. Proteinuria in preeclampsia: not essential to diagnosis but related to disease severity and fetal outcomes. Pregnancy Hypertens. 2017;8:60–64.
- Kim MJ, Kim YN, Jung EJ, et al. Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia? Obstet Gynecol Sci. 2017;60(3):260–265.